866
Views
14
CrossRef citations to date
0
Altmetric
Articles

The evolution of the pharmaceutical-biotechnology industry

&
Pages 583-601 | Published online: 05 Aug 2008

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (4)

Steve Sturdy. (2017) Personalised Medicine and the Economy of Biotechnological Promise. The New Bioethics 23:1, pages 30-37.
Read now
Edward Kasabov. (2016) Modelling life-science clusters in terms of resources and capabilities. European Planning Studies 24:10, pages 1884-1912.
Read now
Björn Remneland Wikhamn, Wajda Wikhamn & Alexander Styhre. (2016) Open innovation in SMEs: a study of the Swedish bio-pharmaceutical industry. Journal of Small Business & Entrepreneurship 28:2, pages 169-185.
Read now
Cameron M. Ford, Thomas O'Neal & Diane M. Sullivan. (2010) Promoting Regional Entrepreneurship through University, Government, and Industry Alliances: Initiatives from Florida's High Tech Corridor. Journal of Small Business & Entrepreneurship 23:sup1, pages 691-708.
Read now

Articles from other publishers (10)

Oscar Tamburis & Isabella Bonacci. (2019) Clusters and communities: raising the bar towards open innovation 2.0 paradigms. International Journal of Pharmaceutical and Healthcare Marketing 13:3, pages 288-305.
Crossref
Geoffroy Labrouche & Med Kechidi. 2019. Biotechnology. Biotechnology 1556 1580 .
K. D. S. Fernald, H. P. G. Pennings, J. F. van den Bosch, H. R. Commandeur & E. Claassen. (2017) The moderating role of absorptive capacity and the differential effects of acquisitions and alliances on Big Pharma firms' innovation performance. PLOS ONE 12:2, pages e0172488.
Crossref
Geoffroy Labrouche & Med Kechidi. (2016) La stratégie d’innovation ouverte de Sanofi. Journal de gestion et d'économie médicales Vol. 34:1, pages 65-86.
Crossref
Geoffroy Labrouche & Med Kechidi. 2016. Handbook of Research on Driving Competitive Advantage through Sustainable, Lean, and Disruptive Innovation. Handbook of Research on Driving Competitive Advantage through Sustainable, Lean, and Disruptive Innovation 140 164 .
Marcus T. Wolfe & Dean A. Shepherd. (2015) What Do You Have to Say About That? Performance Events and Narratives' Positive and Negative Emotional Content. Entrepreneurship Theory and Practice 39:4, pages 895-925.
Crossref
Jackie Krafft, Francesco Quatraro & Pier Paolo Saviotti. (2014) Knowledge characteristics and the dynamics of technological alliances in pharmaceuticals: empirical evidence from Europe, US and Japan. Journal of Evolutionary Economics 24:3, pages 587-622.
Crossref
Mine Ozer, Irem Demirkan & Omer N. Gokalp. (2013) Collaboration networks and innovation: does corporate lobbying matter?. Journal of Strategy and Management 6:3, pages 286-308.
Crossref
Alexander Styhre. (2011) Competing Institutional Logics in the Biopharmaceutical Industry: The Move away from the Small Molecules Therapies Model in the Post-Genomic Era. Creativity and Innovation Management 20:4, pages 311-329.
Crossref
Matthew Hale, Richard Hawkins & Catherine Wright. (2009) List of publications on the economic and social history of Great Britain and Ireland published in 2008. The Economic History Review 62:4, pages 953-1002.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.